- Home
- WIX vs CORT Comparison
WIX vs CORT Comparison
Compare WIX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIX
- CORT
- Stock Information
- Founded
- WIX 2006
- CORT 1998
- Country
- WIX Israel
- CORT United States
- Employees
- WIX N/A
- CORT N/A
- Industry
- WIX Computer Software: Programming Data Processing
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- WIX Technology
- CORT Health Care
- Exchange
- WIX Nasdaq
- CORT Nasdaq
- Market Cap
- WIX 7.6B
- CORT 7.6B
- IPO Year
- WIX 2013
- CORT N/A
- Fundamental
- Price
- WIX $95.91
- CORT $81.16
- Analyst Decision
- WIX Strong Buy
- CORT Strong Buy
- Analyst Count
- WIX 21
- CORT 5
- Target Price
- WIX $183.76
- CORT $139.00
- AVG Volume (30 Days)
- WIX 1.9M
- CORT 660.5K
- Earning Date
- WIX 11-19-2025
- CORT 11-04-2025
- Dividend Yield
- WIX N/A
- CORT N/A
- EPS Growth
- WIX 47.59
- CORT N/A
- EPS
- WIX 2.36
- CORT 0.87
- Revenue
- WIX $1,929,230,000.00
- CORT $741,172,000.00
- Revenue This Year
- WIX $14.28
- CORT $28.85
- Revenue Next Year
- WIX $13.62
- CORT $34.98
- P/E Ratio
- WIX $40.61
- CORT $91.36
- Revenue Growth
- WIX 13.22
- CORT 17.92
- 52 Week Low
- WIX $92.23
- CORT $49.00
- 52 Week High
- WIX $247.11
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- WIX 23.73
- CORT 61.45
- Support Level
- WIX $92.23
- CORT $73.79
- Resistance Level
- WIX $96.92
- CORT $81.41
- Average True Range (ATR)
- WIX 5.77
- CORT 2.93
- MACD
- WIX -3.33
- CORT 0.71
- Stochastic Oscillator
- WIX 8.46
- CORT 96.44
About WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.